A phase II study to evaluate safety and efficacy of neoadjuvant pembrolizumab and radiotherapy in localized MSS rectal cancer

被引：0
|
作者：
Kossler, Thibaud
Nicolas, Buchs
Dutoit, Valerie
Puppa, Giacomo
Tsantoulis, Petros
Frossard, Jean-Louis
Bichard, Philippe
Montet, Xavier
Mckee, Thomas
Di Marco, Mariagrazia
Dietrich, Pierre-Yves
Roth, Arnaud
Zilli, Thomas
Ris, Frederic
机构：
[1] Geneva Univ Hosp, Geneva, Switzerland
[2] Geneva Univ Hosp, Ctr Oncol, Geneva, Switzerland
[3] Hop Univ Geneve, Geneva 14, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
[5] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS272
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial
    Morielli, Andria R.
    Usmani, Nawaid
    Boule, Normand G.
    Severin, Diane
    Tankel, Keith
    Joseph, Kurian
    Nijjar, Tirath
    Fairchild, Alysa
    Courneya, Kerry S.
    CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 216 - 226
  • [42] The efficacy and safety of neoadjuvant mFOLFOXIRI and XELOX for locally advanced rectal cancer: A retrospective study
    Kodama, Hiroyuki
    Terazawa, Tetsuji
    Yukami, Hiroki
    Aoki, Masahiko
    Asaishi, Ken
    Yamaguchi, Toshifumi
    Kii, Takayuki
    Goto, Masahiro
    Tanaka, Keitarou
    Okuda, Jyunji
    Higuchi, Kazuhide
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
    Powles, Thomas
    Rodriguez-Vida, Alejo
    Duran, Ignacio
    Crabb, Simon J.
    Van der Heijden, Michiel Simon
    Pous, Albert Font
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Long term efficacy results from the phase II CRAB trial: Neoadjuvant bevacizumab, capecitabine and radiotherapy in locally advanced rectal cancer
    Velenik, V.
    Omejc, M.
    Ocvirk, J.
    Edhemovic, I.
    Anderluh, F.
    Oblak, I.
    But-Hadzic, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [45] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    Delrio, P
    Avallone, A
    Guida, C
    Marone, P
    Petrillo, A
    Tatangelo, F
    Di Marzo, M
    Scala, D
    Parisi, V
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S115 - S115
  • [46] A phase I/II study of neoadjuvant chemotherapy with Pemetrexed (Alimta) in rectal cancer
    Derwinger, K.
    Kodeda, K.
    Swartling, T.
    Kalebo, P.
    Carlsson, G.
    Gustavsson, B.
    EJSO, 2011, 37 (07): : 583 - 588
  • [47] Neoadjuvant chemoradiation in locally advanced rectal cancer: Results of a phase II study
    P. Delrio
    A. Avallone
    C. Guida
    P. Marone
    A. Petrillo
    F. Tatangelo
    M. Di Marzo
    D. Scala
    V. Parisi
    Annals of Surgical Oncology, 2004, 11 : S115 - S115
  • [48] NEOADJUVANT MULTIDISCIPLINARY PHASE II STUDY (BRANCH) OF AN EARLY BEVACIZUMAB SCHEDULE PLUS CHEMO-RADIATION THERAPY IN RECTAL CANCER: EFFICACY, SAFETY, AND BIOMARKERS
    Avallone, A.
    Di Gennaro, E.
    Aloj, L.
    Delrio, P.
    Pecori, B.
    Tatangelo, F.
    Petrillo, A.
    Iaffaioli, V. R.
    Lastoria, S.
    Budillon, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 193 - 194
  • [49] Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
    Chen, Robert
    Zinzani, Pier Luigi
    Fanale, Michelle A.
    Armand, Philippe
    Johnson, Nathalie A.
    Brice, Pauline
    Radford, John
    Ribrag, Vincent
    Molin, Daniel
    Vassilakopoulos, Theodoros P.
    Tomita, Akihiro
    von Tresckow, Bastian
    Shipp, Margaret A.
    Zhang, Yinghua
    Ricart, Alejandro D.
    Balakumaran, Arun
    Moskowitz, Craig H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2125 - +
  • [50] A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer
    Zhou, Mingzhen
    Jin, Yuncheng
    Zhu, Sihui
    Xu, Chen
    Li, Lin
    Liu, Baorui
    Shen, Jie
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2024, 13 (01)
12345